Colchicine and high-intensity rosuvastatin in the treatment of non-critically ill patients hospitalised with COVID-19: a randomised clinical trial

Colchicine and high-intensity rosuvastatin in the treatment of non-critically ill patients hospitalised with COVID-19: a randomised clinical trial

Objective To evaluate the effect of colchicine and high-intensity rosuvastatin in addition to standard of care on the progression of COVID-19 disease in hospitalised patients.Design A pragmatic, open-label, multicentre, randomised controlled trial conducted from October 2020 to September 2021. Follo...

Full description

Bibliographic Details
Main Authors: Jing Lu, Christopher Song, Prashant Patel, Christopher Howes, Michael Cleman, Alexandra Lansky, Tayyab Shah, Marianne McCarthy, Irem Nasir, Herb Archer, Elio Ragheb, Jonathan Kluger, Nitu Kashyap, Carlos Paredes, Prakash Kandel, Mustafa Khan, Haocheng Huang, Faheem Ul Haq, Rami Ahmad, Brian Cambi, Gilead Lancaster, Charles Dela Cruz, Helen Parise
Format: Article
Language:English
Published: BMJ Publishing Group 2023-02-01
Series:BMJ Open
Online Access:https://bmjopen.bmj.com/content/13/2/e067910.full

Internet

https://bmjopen.bmj.com/content/13/2/e067910.full

Similar Items